Starting-dose trends over time in biologic-naive and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab

被引：0
|
作者：
Guerin, Annie [1 ]
Sundaram, Murali [2 ]
Gauthier, Genevieve [1 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1348
引用
收藏
页码：AB253 / AB253
页数：1
相关论文
共 50 条
  • [1] ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.
    Borisova, M.
    Lukina, G.
    Yakov, S.
    Luchikhina, E.
    Karateev, D.
    Novikov, A.
    Aleksandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1300 - 1300
  • [2] Health care resource utilization, health care costs, and dose escalation in biologic-naive psoriasis patients initiated on ustekinumab versus adalimumab
    Guerin, Annie
    Sundaram, Murali
    Gauthier, Genevieve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB236 - AB236
  • [3] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [4] Health care utilization and cost implications of biologic treatment patterns among biologic-naive and biologic-experienced patients with moderate to severe psoriasis
    Feidman, Steven
    Palmer, Jacqueline
    Wang, Xinyue
    Tian, Haijun
    Wei, Zhongyuan
    Djatche, Laurence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB151 - AB151
  • [5] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [6] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [7] Predictors of Persistency with TNFi in Biologic-Experienced Versus Biologic-Naive Psa Patients Enrolled in the Corrona Registry
    Etzel, C. J.
    Stolshek, Bradley S.
    Rebello, Sabrina
    Collier, David
    Mutebi, Alex
    Wade, Sally W.
    Malley, Wendi
    Greenberg, J. D.
    Harrold, Leslie R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Characteristics of patients with moderate-to-severe psoriasis treated with secukinumab in US clinical practice-A focus on biologic-naive and biologic-experienced patients
    Feldman, Steven
    Palmer, Jacqueline
    Djatche, Laurence
    Hur, Peter
    Zhao, Yang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB68 - AB68
  • [9] Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced
    Megna, Matteo
    Ruggiero, Angelo
    Torta, Ginevra
    Martora, Fabrizio
    Bianco, Mariateresa
    Potestio, Luca
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1186 - 1189
  • [10] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345